Inter-individual and inter-ethnic differences as well as differences in the severity and progression of liver disease are quite significant among patients with MASLD.
← all excerpts
Team players in the pathogenesis of metabolic dysfunctions-associated steatotic liver disease: The basis of development of pharmacotherapy.
1
—
—